uniQure N.V. (QURE) DCF Valuation

Valoración DCF de uniQure N.V. (QURE)

NL | Healthcare | Biotechnology | NASDAQ
uniQure N.V. (QURE) DCF Valuation

Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets

Diseño Profesional: Plantillas Confiables Y Estándares De La Industria

Predeterminadas Para Un Uso Rápido Y Eficiente

Compatible con MAC / PC, completamente desbloqueado

No Se Necesita Experiencia; Fáciles De Seguir

uniQure N.V. (QURE) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Evalúe las perspectivas financieras de Uniqure N.V. como un profesional! Esta calculadora DCF (QURE) proporciona datos financieros preconsados ​​y le permite modificar fácilmente suposiciones como el crecimiento de los ingresos, WACC, los márgenes y más para alinearse con sus predicciones.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020
AY2
2021
AY3
2022
AY4
2023
AY5
2024
FY1
2025
FY2
2026
FY3
2027
FY4
2028
FY5
2029
Revenue 37.5 524.0 106.5 15.8 27.1 27.6 28.0 28.4 28.9 29.3
Revenue Growth, % 0 1296.82 -79.68 -85.12 71.17 1.59 1.59 1.59 1.59 1.59
EBITDA -127.0 319.0 -108.0 -253.1 -160.7 -18.7 -19.0 -19.3 -19.6 -19.9
EBITDA, % -338.46 60.88 -101.44 -1597.55 -592.74 -67.82 -67.82 -67.82 -67.82 -67.82
Depreciation 10.6 7.3 8.5 11.9 12.6 8.8 8.9 9.1 9.2 9.4
Depreciation, % 28.38 1.39 8.02 75.11 46.61 31.9 31.9 31.9 31.9 31.9
EBIT -137.6 311.7 -116.6 -265.0 -173.4 -18.8 -19.1 -19.4 -19.7 -20.0
EBIT, % -366.84 59.48 -109.46 -1672.66 -639.35 -68.1 -68.1 -68.1 -68.1 -68.1
Total Cash 244.9 556.3 352.8 617.9 367.5 27.6 28.0 28.4 28.9 29.3
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 6.6 58.8 102.4 4.2 5.9
Account Receivables, % 17.64 11.22 96.14 26.47 21.69
Inventories 4.3 10.5 6.9 12.0 .0 5.3 5.4 5.5 5.5 5.6
Inventories, % 11.56 2.01 6.5 75.89 0 19.19 19.19 19.19 19.19 19.19
Accounts Payable 3.8 2.5 11.0 6.6 7.2 4.9 5.0 5.1 5.1 5.2
Accounts Payable, % 10.05 0.47748 10.32 41.57 26.65 17.81 17.81 17.81 17.81 17.81
Capital Expenditure -9.5 -17.4 -17.7 -7.2 -3.4 -5.7 -5.8 -5.8 -5.9 -6.0
Capital Expenditure, % -25.28 -3.33 -16.61 -45.16 -12.42 -20.56 -20.56 -20.56 -20.56 -20.56
Tax Rate, % -1.02 -1.02 -1.02 -1.02 -1.02 -1.02 -1.02 -1.02 -1.02 -1.02
EBITAT -121.6 308.7 -115.2 -266.7 -175.2 -18.2 -18.5 -18.8 -19.1 -19.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -127.7 238.9 -155.9 -173.2 -154.9 -26.4 -15.5 -15.8 -16.0 -16.3
WACC, % 12.25 13.2 13.19 13.29 13.29 13.05 13.05 13.05 13.05 13.05
PV UFCF
SUM PV UFCF -65.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -17
Terminal Value -150
Present Terminal Value -81
Enterprise Value -146
Net Debt -93
Equity Value -54
Diluted Shares Outstanding, MM 49
Equity Value Per Share -1.10

What You Will Get

  • Real QURE Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust discount rates, tax implications, revenue projections, and capital investments.
  • Dynamic Calculations: Automatically computes intrinsic value and NPV in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess uniQure’s future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • 🔍 Real-Life QURE Financials: Pre-filled historical and projected data for uniQure N.V. (QURE).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate uniQure’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize uniQure’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Obtain the pre-formatted Excel file containing uniQure N.V.’s (QURE) financial data.
  • Customize: Modify projections, such as revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various forecasts and analyze results immediately.
  • Make Decisions: Leverage the valuation outcomes to inform your investment approach.

Why Choose This Calculator for uniQure N.V. (QURE)?

  • Accurate Data: Access to up-to-date uniQure financials guarantees trustworthy valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
  • Time-Saving: Built-in calculations save you the hassle of starting from square one.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants focused on uniQure.
  • User-Friendly: An intuitive design and clear instructions make it accessible for all users.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and trustworthy valuation models for analyzing portfolios involving uniQure N.V. (QURE).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Deliver precise valuation insights to clients interested in uniQure N.V. (QURE) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like uniQure N.V. (QURE) are valued in the financial markets.

What the Template Contains

  • Historical Data: Includes uniQure N.V.'s past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate uniQure N.V.'s intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of uniQure N.V.'s financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.